Holen Sie sich die Stockscreener-App
3.75
1.06%
-0.04
Handel nachbörslich:
3.75
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RCEL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.79
Offen:
$3.76
24-Stunden-Volumen:
292.42K
Relative Volume:
0.52
Marktkapitalisierung:
$114.35M
Einnahmen:
$50.14M
Nettoeinkommen (Verlust:
$-35.38M
KGV:
-2.6786
EPS:
-1.4
Netto-Cashflow:
$-39.46M
1W Leistung:
-2.85%
1M Leistung:
-5.54%
6M Leistung:
-40.29%
1J Leistung:
-71.89%
1-Tages-Spanne:
$3.64
$3.84
1-Wochen-Bereich:
$3.64
$4.09
52-Wochen-Spanne:
$3.35
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Firmenname
Avita Medical Inc
Sektor
Branche
Telefon
661-568-1317
Adresse
28159 AVENUE STANFORD, VALENCIA, CA
Vergleichen Sie RCEL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.75 | 115.57M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
127.19 | 222.77B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.04 | 143.62B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
370.22 | 140.84B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
103.21 | 129.80B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
84.71 | 49.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Hochstufung | BTIG Research | Sell → Neutral |
| 2025-08-08 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-12-24 | Eingeleitet | D. Boral Capital | Buy |
| 2024-04-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-27 | Eingeleitet | BofA Securities | Buy |
| 2020-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-03 | Eingeleitet | BTIG Research | Buy |
Alle ansehen
Avita Medical Inc Aktie (RCEL) Neueste Nachrichten
Avita Medical (NASDAQ:RCEL) Upgraded at BTIG Research - MarketBeat
Why AVITA Medical Inc. stock is favored by top institutionsJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
BTIG Upgrades AVITA Medical (RCEL) - Nasdaq
AVITA Medical Inc (RCEL) Stock News & Articles - 24/7 Wall St.
RCEL Upgraded by BTIG: New Neutral Rating | RCEL Stock News - GuruFocus
BTIG upgrades Avita Medical stock rating to Neutral from Sell By Investing.com - Investing.com Canada
How AVITA Medical Inc. stock performs in high volatility marketsMarket Performance Summary & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Investors to Connect - ACCESS Newswire
Will AVITA Medical Inc. stock benefit from commodity pricesMarket Rally & Growth Oriented Trade Recommendations - newser.com
How to escape a deep drawdown in AVITA Medical Inc.2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
Leading vs lagging indicators on AVITA Medical Inc. performanceJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Historical volatility pattern of AVITA Medical Inc. visualizedMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Q2 2025 AVITA Medical Inc Earnings Call Transcript - GuruFocus
Is AVITA Medical Inc. stock attractive for income investors2025 Price Action Summary & High Return Trade Guides - newser.com
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Why AVITA Medical Inc. stock remains a top recommendationWeekly Trade Report & Community Verified Trade Alerts - newser.com
How AVITA Medical Inc. stock performs during Fed tightening cycles2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
How AVITA Medical Inc. stock performs in weak economyWeekly Market Report & Comprehensive Market Scan Reports - newser.com
How analysts rate AVITA Medical Inc. stock todayJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Connect - ACCESS Newswire
What analysts say about AVITA Medical Inc stockDividend Stability Analysis & Free High Frequency Trading Ideas - earlytimes.in
Brokers Offer Predictions for Avita Medical FY2025 Earnings - MarketBeat
How AVITA Medical Inc. stock performs in interest rate cyclesQuarterly Portfolio Report & AI Powered Market Entry Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Reach Out - ACCESS Newswire
AVITA Medical (RCEL) Q3 2025 Earnings Transcript - AOL.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AVITA Medical, Inc. (RCEL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bragar Eagel & Squire, P.C. Is Investigating Agilon, - GlobeNewswire
AVITA Medical Hits 52-Week Low at $3.37 Amidst Significant Decline - Markets Mojo
AVITA Medical Hits 52-Week Low at $3.35 Amid Significant Decline - Markets Mojo
Using AI based signals to follow AVITA Medical Inc.July 2025 Snapshot & High Accuracy Trade Alerts - newser.com
Is AVITA Medical Inc. stock a top pick in earnings seasonTrade Entry Report & Entry Point Strategy Guides - newser.com
Avita signals revenue recovery with $70M–$74M 2025 outlook following reimbursement clarity - MSN
How Volatile Is Azad Engineering Limited Compared to PeersMarket Liquidity Analysis & Access Risk Ratings for Every Stock - earlytimes.in
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
Finanzdaten der Avita Medical Inc-Aktie (RCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avita Medical Inc-Aktie (RCEL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
| McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
1.92%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):